Scaling would be on shares held on the record date of 8 December 2021. So any buying or purchasing now won't alter anything.
Printable View
Gee the SP is getting up their.
Taking some profits today..
Big volume at close of play.
Does EBO have any part in distribution of ANTI GEN testing. Chemists looks like they are going to be the front line in AUS and pretty soon here :scared:
It's an interesting mentality question - how much/how hard does an existing shareholder take up their maximum NZ$50k investment?
Baring any new announcements / holding all else equal - it's interesting to me that as the SP rocketed up to +$40 I'm more of the view that I'll take up all that I can, given the SPP is $34.5 (or thereabouts). But if the SP had fallen and was below the recent rights issue, say at 33, even though I'd be getting more shares for my dollar, I'd be more relaxed about not taking up the maximum. Bit of my own psychology flaws I guess.
Rather academic though, isn't it? It seems inevitable that the issue will be heavily oversubscribed and applications heavily scaled back
I guess for small players like myself, knowing it would be scaled back based on number of shares held, but still needing cash for other purposes if it all went through.
I assumed I'd be scaled back to the circa 11% dilution of number of shares held.
I applied for twice as much of that 11% number i.e. using an easy example: Hold 1000 shares, applied for 220 @ $34.5, $7590.
So I only put in $25,000 into the application just in case it all went through I'd have fund available to pay my upcoming provisional tax.
Thought $34.50 is fair value at this stage. Similar thoughts to Fiordland Moose, my target price for accumulating would be sub $30 on the open market.
Wanted to subscribe to the offer but not impressed when this is what I got:
"Due to legal restrictions, access to this website is only available to residents of Australia and New Zealand from within Australia or New Zealand. In order to access this website, you must provide the State, Territory or Region and postcode for your primary residential address within Australia or New Zealand.
Persons accessing this website from outside of Australia or New Zealand must exit this website immediately."
lets take a poll - what will the scaling be - IE the % number of shares given on the number of shares requested...I have no idea - i'll say 60% scaling.
85 percent. To be safe I’m applying for 30 percent of my holding.
Put in for 50k just in case, hopefully will get at least 10k worth, not expecting anymore than 20k worth.
Agreed.
I'm not going to bother to apply for the full $50k
I don't think my 1000 shares are going to get me a big allocation
I wish they would do a non renounceable pro rata rights allocation with the option to put in for extra in any shares aren't claimed
So much easier and better on my wallet
I feel we will get less than 10% of our current shareholding
I think it will be 8% but hoping for more.
Going off of shareholder metrics from the last report.
67 entities hold over 100k shares each, and own 82% of the stock
571 entities hold 10k-100k shares each, and own 8% of the stock. I assume the average member of this group owns 20,000 shares (not a guess, this is based on report data)
If these groups apply for the maximum of $50,000, they should receive ~1450 shares each, as a group they would take about 925,000 shares from the ~3,000,000 shares on offer. All entities within these groups will receive their maximum entitlement for all scaling levels above 7.5%.
This leaves ~2,075,000 shares for the rest, the rest being:
Group 1 - 761 entities with 5k-10k shares, I will assume the average member of this group has 7.5k shares.
Group 2 - 3744 entities with 1k-5k shares, I will assume the average member of this group has 2.5k shares.
Group 3 - 6507 entities with 1-1k shares, I will assume the average member of this group has 500 shares.
If we assume all holders are scaled to 20% of their current shareholding:
Group 1 - 761 entities receive the maximum entitlement of 1450 shares, 1,100,000 shares in total
Group 2 - 3744 entities receive 500 shares, 1,872,000 shares in total
Group 3 - 6507 entities receive 100 shares, 650,700 shares in total
This scenario exceeds the number of shares available by around 1,500,000 shares.
If we assume all holders are scaled to 10% of their current shareholding:
Group 1 - 761 entities receive 1125 shares, 856,125 shares in total
Group 2 - 3744 entities receive 375 shares, 1,404,000 shares in total
Group 3 - 6507 entities receive 75 shares, 488,025 shares in total
This scenario exceeds the number of shares available by around 670,000 shares.
If we assume all holders are scaled to 10% of their current shareholding:
Group 1 - 761 entities receive 750 shares, 570,750 shares in total
Group 2 - 3744 entities receive 250 shares, 936,000 shares in total
Group 3 - 6507 entities receive 50 shares, 325,350 shares in total
This scenario leaves 242,900 shares unallocated.
As this doesn't account for the impacts of the recent placement, assumes all entities request their full entitlement of $50,000 and assumes all entities in each group have the same number of shares (the average) it will be somewhat inaccurate. Having said this, I expect the scaling to be somewhere between 10% and 14% with no oversubscriptions.
When do we find out our allocation?
Record date (for identifying shareholders eligible to
participate in the Retail Offer)
7:00pm (NZDT) / 5:00pm (AEDT)
Wednesday, 8 December 2021
Retail Offer opens and Retail Offer Document is dispatched Wednesday, 15 December 2021
Retail Offer closes 7:00pm (NZDT) / 5:00pm (AEDT)
Monday, 17 January 2022
Retail Offer Issue Price announced Tuesday, 18 January 2022
Retail Offer allotment date Monday, 24 January 2022
Commencement of normal trading of new shares issued under
the Retail Offer on NZX Main Board Monday, 24 January 2022
Commencement of normal trading of new shares issued under
the Retail Offer on ASX Tuesday, 25 January 2022
Despatch of holding statements Friday, 28 January 2022
Hi all. There have been no announcements yet on the outcome of the retail offer but I have just checked via Computershare and see I have an allotment that works out at 13.74% of my existing holding at record date...heavily scaled and around the level that it seems some brokers were expecting.
Allocated 412 shares 13.7%. Applied for $50k
Ditto 13.7% of existing shareholding
Waiting for my refund...
Refunds due on Friday
I wish they were faster with refunds
Where can you see your allocation? I have heard nothing.
As expected got 14 percent. Have brought more on market today. Bottom drawer material this one.
Fisher have added EBO to their Kingfish Fund
That's good
Pleasantly surprised to receive a full allocation for my $30,000 - less $19.50 refund .
:)
Strange disclosure from one of the directors today. I hope it is in error. Nicholas Dowling, starting page 5 of the disclosure, discloses an on-market sale 20 days ago, in a closed period and which he didn't seek approval either. Any thoughts? Have I got this wrong maybe?
Its a pretty basic requirement. I still have to file disclosure until 6 months after ceasing to be a director, still have to get clearance regardless of whether it is a closed period or open.
I saw that. It actually needs the company to explain.
The whole thing is turning to custard over in NSW, probably still a good buy price right here for the future since the Offer burped up so few chips...
pulls back to low 35-36 a buy on the dip if it ever does.
See the company didn't respond to the NBR's enquiry. The "Just ignore it, it will go away" strategy. How arrogant! Bad strategy. Law apparently doesn't apply to these guys. Obvious FMA now enquiring. The Chairman should have been lead in this and the director should have stood down. Now it will become more than it should have been and the Chairman looks ineffectual.
This seems pretty abrupt…
https://www.nzx.com/announcements/386907
EBOS Group Limited (EBOS) advises that Mr Nick Dowling has resigned as a director of EBOS with effect from today
EBOS should just have said why. It is pretty obvious. I hope the FMA hasn't done a deal where the director goes and no action. Either EBOS comes out and says the guy "breached all its rules and the company demanded his resignation. The company is cooperating with the FMA and has agreed to a fine of Xx in respect of the breach" or this is a green light for companies to try it on and then do something later to fix it but avoid any action or not. CMON FMA shows us your fangs, defend your regs or might as well have your year end Xmas party now and close up shop.
What is a restricted period for directors selling shares?
All covered in here tango
https://ebosgroup.gcs-web.com/static...1-fd0ed8f98986
Half Year:
Half Year Results - NZX, New Zealand’s Exchange
Key highlights of the first half included:
• Revenue of $5.3 billion (up 12.8%);
• Underlying Net Profit after Tax of $109.3 million (up 15.8%);o $7.4 million of M&A transaction costs (post-tax) were incurred in Statutory NPAT.
• Underlying EPS of 66.6 cents up 15.2%;
• Interim dividend declared of NZ 47.0 cents per share (up 10.6%);
• Continued strong performances from both our Healthcare and Animal Care segments, with Healthcare’s Underlying EBIT up 17.0% and Animal Care’s EBIT up 14.9%;
• Operating cash flow of $106.8 million (up 8.1%);
• Consistent with our strategy of investing for growth and as previously announced:o the Group completed three acquisitions to further expand its Institutional Healthcare division, including Sentry Medical, Pioneer Medical and MD Solutions; ando the Group reached agreement to acquire LifeHealthcare, which will establish EBOS as a leading distributor of medical devices in Australia, New Zealand and South East Asia.
• Commenced the commissioning phase of our new state of the art pet food manufacturing facility in Parkes, NSW.
A$1 Underlying Results Statutory ResultsTotal Revenue $5,250.9m up 12.8% $5,250.9m up 12.8%
EBITDA $207.7m up 12.8% $199.9m up 9.7%
EBIT $169.1m up 14.4% $161.3m up 10.6%
Net Profit after Tax $109.3m up 15.8% $101.9m up 9.7%
Earnings per Share 66.6 cents up 15.2% 61.4 cents up 8.0%
Operating cash flow n/a $106.8m up 8.1%
ROCE 18.2% up 0.7% n/aNet Debt :
EBITDA2 1.28x up 0.28x n/a
Interim Dividend n/a NZ 47.0cps up 10.6
EBO has done it again ...its showing consistent growth and strong outlook ....this growth stock still performing .
Always delivers, never lost any sleep over this one
Wow EBO almost 5% up today ...who says growth or high p/e stocks will not work in this market ....if u show consistent growth then market rewards with higher SP .
Holding so very delighted that its done so well in such environment too !
EBO into NZX10 Index, ATM out...
Nicely green today in my sea of red.
Ebos is one of the very few companies that have a long history of eps growth on the NZX. For me it’s a bottom draw share that commands a large position in my portfolio.
The current price in my view is no bargain but think $50 is a real possibility this year. You have to pay for quality and with the current acquisition I think well worth the current forward PE.
EBO one of a few stocks not really been affected by the bear market
Share price up 22% over last 52 weeks ….that’s pretty awesome
Acquisitions been favourably received - shares been rerated
fully valued at the MO Winner(n->SP).
Yep, fully valued but a great long-term investment in this uncertain environment.
winner(n) that is near perfection.
just saying how much longer can perfection continue.
Been an amazing run so far and of course "very profitable"
R Quest.
Don't think so
Currently trading PE of 28 on expected FY22 earnings and with growth profile this PE is sustainable
Lifehealthcare impact acquisition not totally recognised by market yet. Best part is Lifehealthcare margins are far superior than current EBOS margins so in total we should see improved margins from here on in ...that's the margin covered off
So even if paying top dollar for top dollar both PE and margin are sustainable
Attachment 13878
Pretty nice looking graph....
Always one of those companies that seems too expensive, but keeps on keeping on. Although is there a point where they "max out" and can't grow anymore, in NZ at least.
In the current environment, much of their business is recession-proof, or at least recession resilient. Health is one thing, but people will always spend on their pet.....
EBO close to 200 ema again. A fortnight ago it bounced off it. How about that for some technical analysis lol
just wondering if EBO will fall into a downtrend like its better hotter sister MFT..
EBO trading on a hefty multiple as well.
One to watch i guess
EBO is our shatetrader forum pick also ...alongwith Craigs and Forbar ...
Why its languishing around support for long ? Results round the corner with many analysts positive
I am looking forward to 24th August for a great result
Th market doesn't appear to have ascribed the value of the LifeHealthcare acquisition yet
Something with much higher margins than EBO been used to - could be a game changer
Hopefully get an update on what they expect for F23 - only had LifrHealthcare for a month or so
As always U r spot on ...see analysts future financial calls this year 239 M NPAT and next 315 M ....big jump in margins also
I think its a great buy now before results and then market wakes up
https://www.marketscreener.com/quote...59/financials/
May jump 10% on results day
The High P/E with inflation up may limit the bounces..
but that increase in NPAT is material for sure...
Full Year Results - NZX, New Zealand’s Exchange
EBOS’ STRONG PERFORMANCE HAS CONTINUED WITH ANOTHER RECORD RESULT AND DOUBLE-DIGIT EARNINGS GROWTHFull Year Highlights
• Revenue of $10.7 billion, exceeding $10 billion for the first time (up 16.6%)
• Underlying Net Profit after Tax (“Underlying NPAT”)of $228.2 million (up 21.3%)o $25.6 million of M&A transaction costs (post-tax) were incurred in Statutory NPAT
• Final dividend declared of NZ 49.0 cents per share, bringing total dividends declared for the year to NZ 96.0 cents per share (up 8.5%)
• Continued strong performances from both our Healthcare and Animal Care segments, with Healthcare’s Underlying EBIT up 24.0% and Animal Care’s EBIT up 15.3%
• Underlying operating cash flow (before capex) of $291.0 million (down 3.7%) reflecting higher investment in working capital and tax payments
• Consistent with our strategy of investing for growth, in FY22 we: o continued to invest in our operational infrastructure across the Group to support the growth in the business; and o completed five acquisitions in a further expansion of our Institutional Healthcare division, including the material acquisition of LifeHealthcare which establishes EBOS as one of the largest independent medical device distributors in Australia, New Zealand and SoutheastAsia
• LifeHealthcare performed in line with expectations during June 2022, the first month under EBOS’ ownership, contributing $9.5 million of EBITDA
• Net Debt : EBITDA of 1.94x (0.85x at June 2021), reflecting our recent investments and remaining within the Group’s target gearing range
Never let us down. Steady as she goes
Analysts just don’t get
Ebos lifted profit 21% in FY22 but analysts are asking how long it can last
https://businessdesk.co.nz/article/m...ng-it-can-last
May be psywalled
Dividends appear to be almost completely unimputated.
Perhaps they should shift HQ to Oz?
looks good but that pesky statutory net profit not up so much. the difference is M+A so I guess thats like an investment really innit? given their record i guess thats ok...
mind the GAAP.
I topped up on Ebos and am surprised that I got them so cheaply. Wake up market!
More than the low of the day!! Around $38.50
EBO share price back over $40
After the good result and people realising LifeHealth going to create a step change in profitability from F23 onwards we should see share price marching on to $50 next year sometime
yes Winner() ! its those high P/E's at work again when the world wobbles on its axes...